Agios Pharmaceuticals (AGIO) Change in Receivables (2015 - 2026)
Agios Pharmaceuticals (AGIO) posted Change in Receivables of $5.6 million for Q1 2026, little changed on a QoQ basis from $5.5 million in Q4 2025, and up 826.14% year-over-year from $599798.9 in Q1 2025.
Agios Pharmaceuticals (AGIO) Change in Receivables (2015 - 2026) Analysis & Trends
Agios Pharmaceuticals' Change in Receivables history runs 8 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- Quarterly Change in Receivables rose 826.14% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.8 million (up 11832.11% YoY) and the FY2025 annual result came in at $6.5 million, up 397.92% from the prior year.
- Change in Receivables was $5.6 million for Q1 2026 at Agios Pharmaceuticals, roughly flat from $5.5 million in the prior quarter.
- Across five years, Change in Receivables topped out at $5.6 million in Q1 2026 and bottomed at -$1.1 million in Q3 2023.
- A 5-year average of $948941.2 and a median of $473000.0 in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables tumbled 588.64% — and 2026, when it jumped 826.14%.
- Agios Pharmaceuticals' Change in Receivables stood at $388000.0 in 2022, then soared by 321.13% to $1.6 million in 2023, then plunged by 39.35% to $991000.0 in 2024, then surged by 459.84% to $5.5 million in 2025, then advanced by 0.13% to $5.6 million in 2026.
- Business Quant data shows AGIO's Change in Receivables at $5.6 million in Q1 2026, $5.5 million in Q4 2025, and $43000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | 5.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.56 Mn |
| Mar 31, 2026 | 5.56 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 43,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Mar 31, 2025 | -765,000.00 |
| Mar 31, 2025 | -765,000.00 |
| Dec 31, 2024 | 991,000.00 |
| Dec 31, 2024 | 991,000.00 |
| Sep 30, 2024 | -644,000.00 |
| Sep 30, 2024 | -644,000.00 |
| Jun 30, 2024 | 309,000.00 |
| Jun 30, 2024 | 309,000.00 |
| Mar 31, 2024 | 643,000.00 |
| Mar 31, 2024 | 643,000.00 |
| Dec 31, 2023 | 1.63 Mn |
| Dec 31, 2023 | 1.63 Mn |